Risk for Clostridioides difficile (C. diff) infection wasn't any greater with vedolizumab (Entyvio) versus anti-tumor necrosis factor (TNF) agents for ulcerative colitis, a researcher reported. In a ...

Since its introduction in 2011, adoption of diverting loop ileostomy for fulminant Clostridioides difficile colitis has more than doubled, and the procedure appeared to be a viable alternative to ...

Four patients with severe disease were cured after receiving the new broad-spectrum antibiotic tigecycline. When patients with Clostridium difficile colitis do not respond to usual treatment with ...

Fecal microbiota transplantation has become one of the most effective treatments for recurrent Clostridioides difficile infections, but its long-term role in gastroenterology may hinge on moving ...

Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by recurrent intestinal inflammation, abdominal ...

Fecal microbiota transplant was noninferior to vancomycin as the initial treatment for C. diff in a randomized, open-label trial. Transplant showed slightly higher cure rates without recurrence and ...